This is supported by findings showing that methyl cap binding protein-2 (MeCP2), which methylates the SFRP1 and DKK1 promoter regions, is overexpressed in SSc fibroblasts, resulting in reduced expression of its target genes [126,127]. The gene discussed is SFRP1; the disease is systemic sclerosis.